Paul Tudor Jones II's position in Integra Lifesciences Holdings is currently worth $2.68 Million. That's 0.03% of their equity portfolio (575th largest holding). The first Integra Lifesciences Holdings trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 25 more times and sold shares on seventeen occasions. The investor's estimated purchase price is $10.7 Million, resulting in a loss of 75%.